Literature DB >> 20414772

PET-guided prostate cancer radiotherapy: technological innovations for dose delivery optimisation.

Giovanni Lucignani1, Habib Zaidi.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20414772     DOI： 10.1007/s00259-010-1478-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  11 in total

Review 1.  PET-guided delineation of radiation therapy treatment volumes: a survey of image segmentation techniques.

Authors:  Habib Zaidi; Issam El Naqa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-25       Impact factor: 9.236

Review 2.  PET-CT for treatment planning in prostate cancer.

Authors:  M Picchio; C Crivellaro; G Giovacchini; L Gianolli; C Messa
Journal:  Q J Nucl Med Mol Imaging       Date:  2009-04       Impact factor: 2.346

3.  Validation of automatic target volume definition as demonstrated for 11C-choline PET/CT of human prostate cancer using multi-modality fusion techniques.

Authors:  Hyunjin Park; Charles R Meyer; David Wood; Asra Khan; Rajal Shah; Hero Hussain; Javed Siddiqui; Jongbum Seo; Thomas Chenevert; Morand Piert
Journal:  Acad Radiol       Date:  2010-02-26       Impact factor: 3.173

4.  Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer.

Authors:  Jan Seppälä; Marko Seppänen; Eveliina Arponen; Paula Lindholm; Heikki Minn
Journal:  Radiother Oncol       Date:  2009-09-18       Impact factor: 6.280

5.  18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer.

Authors:  Hui Wang; Hansjörg Vees; Raymond Miralbell; Michael Wissmeyer; Charles Steiner; Osman Ratib; Srinivasan Senthamizhchelvan; Habib Zaidi
Journal:  Radiother Oncol       Date:  2009-09-18       Impact factor: 6.280

6.  Case study of anti-1-amino-3-F-18 fluorocyclobutane-1-carboxylic acid (anti-[F-18] FACBC) to guide prostate cancer radiotherapy target design.

Authors:  Ashesh B Jani; Timothy H Fox; Daisy Whitaker; David M Schuster
Journal:  Clin Nucl Med       Date:  2009-05       Impact factor: 7.794

Review 7.  Molecular PET/CT imaging-guided radiation therapy treatment planning.

Authors:  Habib Zaidi; Hansjörg Vees; Michael Wissmeyer
Journal:  Acad Radiol       Date:  2009-05-08       Impact factor: 3.173

8.  Detection of aggressive primary prostate cancer with 11C-choline PET/CT using multimodality fusion techniques.

Authors:  Morand Piert; Hyunjin Park; Asra Khan; Javed Siddiqui; Hero Hussain; Thomas Chenevert; David Wood; Timothy Johnson; Rajal B Shah; Charles Meyer
Journal:  J Nucl Med       Date:  2009-09-16       Impact factor: 10.057

9.  In vivo verification of proton beam path by using post-treatment PET/CT imaging.

Authors:  Wen C Hsi; Daniel J Indelicato; Carlos Vargas; Srividya Duvvuri; Zuofeng Li; Jatinder Palta
Journal:  Med Phys       Date:  2009-09       Impact factor: 4.071

10.  RapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: a treatment planning comparison study.

Authors:  Damien C Weber; Hui Wang; Luca Cozzi; Giovanna Dipasquale; Haleem G Khan; Osman Ratib; Michel Rouzaud; Hansjoerg Vees; Habib Zaidi; Raymond Miralbell
Journal:  Radiat Oncol       Date:  2009-09-09       Impact factor: 3.481
View more
  1 in total

1.  Analysis of intraprostatic therapeutic effects in prostate cancer patients using [(11)C]-choline pet/ct after external-beam radiation therapy.

Authors:  J Amanie; H S Jans; M Wuest; N Pervez; A Murtha; N Usmani; D Yee; R Pearcey; B Danielson; S Patel; R Macewan; C Field; D Robinson; J Wilson; D Lewis; M Parliament; A J B McEwan
Journal:  Curr Oncol       Date:  2013-04       Impact factor: 3.677
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.